Stock & Company Details
Biomea Fusion Inc $BMEA
Price:
N/A
N/A
72M
$47M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.25
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BMEA technical indicators
Latest Biomea Fusion Inc (BMEA) indicator readings as of 2026-10-29.
BMEA's 14-day RSI is 25.5, in oversold territory. At $0.62 it is trading 54.8% below its 200-day moving average of $1.38, and below its 50-day average of $1.37. Price sits in the middle of its Bollinger Bands ($0.34 to $1.57). ADX reads 41.8, indicating a trending market.
Overview
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
Finance Bot
Ask your questions
Start by typing a question below.
